(Q62812962)

English

Daratumumab in Treating Transplant-Eligible Participants With Multiple Myeloma

clinical trial

Statements

Phase II Trial of Daratumumab for Transplant-Eligible Multiple Myeloma Patients (English)
0 references
0 references
9 April 2018
0 references
1 April 2019
0 references
50
0 references
18 year
0 references
64 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit